Wan-li Wang

State Key Laboratory Of Oral Diseases & National Center For Stomatology & National Clinical Research Center For Oral Diseases & Department Of Oral And Maxillofacial Surgery
China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Multi-omics profiling of ACOX3 unveils pan-cancer clinical biomarker potential.

Multi-omics profiling of ACOX3 unveils pan-cancer clinical biomarker potential.

Journal: Computational biology and chemistry

Published: July 30, 2025

An injectable hydrogel with photothermal and chemodynamic therapies for targeted promotion of ferroptosis in oral squamous cell carcinoma.

An injectable hydrogel with photothermal and chemodynamic therapies for targeted promotion of ferroptosis in oral squamous cell carcinoma.

Journal: Nanoscale

Published: April 02, 2025

Cancer pain: molecular mechanisms and management.

Cancer pain: molecular mechanisms and management.

Journal: Molecular biomedicine

Published: September 02, 2024

Identification of ACAA1 and HADHB as potential prognostic biomarkers based on a novel fatty acid oxidation-related gene model in head and neck squamous cell carcinoma: A retrospective study.

Identification of ACAA1 and HADHB as potential prognostic biomarkers based on a novel fatty acid oxidation-related gene model in head and neck squamous cell carcinoma: A retrospective study.

Journal: Archives of oral biology

Published: January 21, 2024

Design, synthesis and biological evaluation of novel 9-methyl-9H-purine and thieno[3, 2-d]pyrimidine derivatives as potent mTOR inhibitors.

Design, synthesis and biological evaluation of novel 9-methyl-9H-purine and thieno[3, 2-d]pyrimidine derivatives as potent mTOR inhibitors.

Journal: Bioorganic chemistry

Published: September 11, 2022

Identification of a selective BRD4 PROTAC with potent antiproliferative effects in AR-positive prostate cancer based on a dual BET/PLK1 inhibitor.

Identification of a selective BRD4 PROTAC with potent antiproliferative effects in AR-positive prostate cancer based on a dual BET/PLK1 inhibitor.

Journal: European journal of medicinal chemistry

Published: August 17, 2021

Identification of a potent and selective phosphatidylinositol 3-kinase δ inhibitor for the treatment of non-Hodgkin's lymphoma.

Identification of a potent and selective phosphatidylinositol 3-kinase δ inhibitor for the treatment of non-Hodgkin's lymphoma.

Journal: Bioorganic chemistry

Published: June 21, 2020

Design, synthesis and structure-activity relationship study of piperazinone-containing thieno[3,2-d]pyrimidine derivatives as new PI3Kδ inhibitors.

Design, synthesis and structure-activity relationship study of piperazinone-containing thieno[3,2-d]pyrimidine derivatives as new PI3Kδ inhibitors.

Journal: Bioorganic & medicinal chemistry letters

Published: April 21, 2020

Design, synthesis, and biological evaluation of 4,5-dihydro-[1,2,4]triazolo[4,3-f]pteridine derivatives as novel dual-PLK1/BRD4 inhibitors.

Design, synthesis, and biological evaluation of 4,5-dihydro-[1,2,4]triazolo[4,3-f]pteridine derivatives as novel dual-PLK1/BRD4 inhibitors.

Journal: European journal of medicinal chemistry

Published: July 25, 2019

Showing 1-9 of 9

Last Updated: 09/26/2026